Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$954M |
| 2 |
Salesforce
CRM
|
+$683M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$620M |
| 4 |
HCA Healthcare
HCA
|
+$560M |
| 5 |
Netflix
NFLX
|
+$445M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$861M |
| 2 |
Incyte
INCY
|
+$755M |
| 3 |
NVIDIA
NVDA
|
+$655M |
| 4 |
Charles Schwab
SCHW
|
+$534M |
| 5 |
MetLife
MET
|
+$373M |
Sector Composition
| 1 | Financials | 19.84% |
| 2 | Technology | 15.57% |
| 3 | Industrials | 8.44% |
| 4 | Healthcare | 8.44% |
| 5 | Energy | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Renaissance IPO ETF
IPO
$190M
| $64K | ﹤0.01% |
1,962
-410
| -17% | -$13.4K |
|
5102
Kymera Therapeutics
KYMR
$3.52B
| $64K | ﹤0.01% |
2,773
+640
| +30% | +$14.8K |
|
5103
Vivid Seats
SEAT
$112M
| $64K | ﹤0.01% |
409
+79
| +24% | +$12.4K |
|
5104
Argan
AGX
$3.31B
| $63K | ﹤0.01% |
1,601
-129
| -7% | -$5.08K |
|
5105
Enliven Therapeutics
ELVN
$1.11B
| $63K | ﹤0.01% |
3,075
+2,589
| +533% | +$53K |
|
5106
Franklin Senior Loan ETF
FLBL
$1.21B
| $63K | ﹤0.01% |
2,600
| – | – |
|
5107
Mitek Systems
MITK
$449M
| $63K | ﹤0.01% |
5,736
-160
| -3% | -$1.76K |
|
5108
Titan International
TWI
$563M
| $63K | ﹤0.01% |
5,472
+2,128
| +64% | +$24.5K |
|
5109
Inspire International ETF
WWJD
$391M
| $63K | ﹤0.01% |
+2,265
| New | +$63K |
|
5110
InfraCap MLP ETF
AMZA
$405M
| $62K | ﹤0.01% |
1,856
+1,200
| +183% | +$40.1K |
|
|
AXDX
5111
DELISTED
Accelerate Diagnostics
AXDX
| $62K | ﹤0.01% |
7,692
-8
| -0.1% | -$64 |
|
5112
Aclaris Therapeutics
ACRS
$204M
| $62K | ﹤0.01% |
5,970
+1,435
| +32% | +$14.9K |
|
|
AGEN
5113
Agenus
AGEN
$145M
| $62K | ﹤0.01% |
1,927
+1,051
| +120% | +$33.8K |
|
5114
Amplify AI Powered Equity ETF
AIEQ
$117M
| $62K | ﹤0.01% |
1,959
-20
| -1% | -$633 |
|
5115
Amprius Technologies
AMPX
$1.12B
| $62K | ﹤0.01% |
8,699
+2,250
| +35% | +$16K |
|
5116
Planet Labs
PL
$3.03B
| $62K | ﹤0.01% |
19,088
-3,100
| -14% | -$10.1K |
|
5117
RxSight
RXST
$379M
| $62K | ﹤0.01% |
2,168
-91
| -4% | -$2.6K |
|
5118
Stoneridge
SRI
$230M
| $62K | ﹤0.01% |
3,319
+1,362
| +70% | +$25.4K |
|
|
GXDW
5119
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$10.9M
| $62K | ﹤0.01% |
2,335
| – | – |
|
|
SOVO
5120
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $62K | ﹤0.01% |
3,200
+320
| +11% | +$6.2K |
|
|
EQRX
5121
DELISTED
EQRx, Inc. Common Stock
EQRX
| $62K | ﹤0.01% |
33,290
+22,025
| +196% | +$41K |
|
5122
Generation Bio
GBIO
$39.9M
| $61K | ﹤0.01% |
1,108
+200
| +22% | +$11K |
|
|
ACB
5123
Aurora Cannabis
ACB
$281M
| $61K | ﹤0.01% |
11,650
-501
| -4% | -$2.62K |
|
5124
Inspire Small/Mid Cap Impact ETF
ISMD
$221M
| $61K | ﹤0.01% |
1,905
-171
| -8% | -$5.48K |
|
5125
Janus International
JBI
$1.43B
| $61K | ﹤0.01% |
5,751
+705
| +14% | +$7.48K |
|